News

The largest-ever vismodegib study in advanced basal cell carcinoma, the STEVIE study, confirms pivotal study findings in a real-world setting, helping dermatologists to provide a complete palette of skin cancer treatments.

New information could eventually help identify a high-risk population before they get cancer - even prevent skin cancer’s onset.

Are doctors liable when patients combine acetaminophen with biologic medications used to treat psoriasis?

An expert advises evaluating each patient’s surrounding circumstances when determining whether Mohs surgery is indicated.

Evidence is mounting for the use of probiotics, prebiotics and microbial lysates in skincare. One expert examines the literature and shares observations.

New technology aims to create a new paradigm in the medical care for survivors of burns and traumatic scars. Jill Waibel shares her experience using lasers for trauma rehabilitation. New non-profit hopes to help injured military heroes and first responders.

Stem cell use in dermatology is part hype and part investigational reality. Experts help separate fact from fiction.

It’s quite a sacrifice to close your practice for a mission trip. One doctor describes her experience and offers resources for other dermatologists interested in volunteering.

Promising treatments under investigation for vitiligo include afamelanotide, prostaglandin analogues and JAK inhibitors. But don't overlook established treatments such as phototherapy and steroid mini-pulses, an expert says.

There’s good evidence to suggest dermatologists who assess psoriasis patients should look beyond the plaques on the skin and consider not just the increased risk to the joints, but also the heart, mind and more.

Oral options in the pipeline for psoriasis show promise.

Facial care advice for patients with acneWhile both benzoyl peroxide acne preparations and vitamin C products carry benefits in acne treatment, it’s wise to recall the characteristics of each element in advising patients on caring for their skin. Vitamin C is rapidly oxidized with exposure to air. Benzoyl peroxide is an oxidant. This is how Dr. Draelos suggests these products be used.

Genetic tests can provide insight even if they don’t point to a cure. Expert explains when it's time to order a test.

Tips to collect and prepare nail specimens that will help improve clinical pathology.

A new wave of sunscreen filters is on the cusp of being approved in the United States after widespread use elsewhere.

One expert summarizes science outside of dermatology that offers insight into the genetic toll of sun damage, the potential skin-protecting effects of vitamin B3, the sun-exposure threat posed by automobile side windows and more.

One dermatologists offers insight into her practice policies and offers strategies to encourage employees and increase profits.

Diagnostic errors are the third leading cause of death. One expert shares strategies for reducing misdiagnosis.

Quality improvement strategies can lead to improved patient care, lower costs, and a fulfilling work environment.

Lice are becoming more resistant to drugs. Understand the threat of resistant lice and the new ways to treat them.

Men who have sex with men-a category that includes gay and bisexual men-have unique needs for dermatologic care because they are at higher risk for some STDs.

Science is finally catching up to common sense when it comes to the idea that stress worsens skin conditions.

Data suggest photodynamic therapy with the investigational topical methyl aminolevulinate may be an effective treatment for patients with severe facial acne.

Mindfulness can be integrated in dermatology management and has been demonstrated in research to improve clearance of conditions for patients and to improve anxiety and depression that patients experience associated with their skin conditions.

The Summer 2016 Meeting of the American Academy of Dermatology kicks off Thursday, July 28, in Boston.

Cheryl Bisera explains the importance of using video in marketing material for your medical practice and also provides tips to make videos effective and powerful.

Results from three phase 3 trials, suggest ixekizumab (Talz, Eli Lilly & Company) is effective through 60 weeks of treatment among patients with moderate-to-severe plaque psoriasis.

The acne app offers a free and immediate analysis of acne type and severity; develops an individualized acne control plan; and monitors users’ progress. It aims to help consumers diagnose, treat, manage and prevent acne.

Mohs surgery experts advise when Mohs is and isn’t optimal skin cancer treatment.

UK-based Ziarco Pharma Ltd. recently announced positive phase 2a results for ZPL-389, a once daily oral histamine H4 receptor antagonist, for the treatment of moderate to severe atopic dermatitis.